VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 634 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $608,827 | +19.4% | 18,820 | +5.8% | 0.06% | +11.1% |
| Q4 2022 | $510,005 | -72.6% | 17,795 | -73.8% | 0.05% | -69.5% |
| Q2 2022 | $1,858,000 | -64.9% | 67,845 | -50.9% | 0.18% | -55.9% |
| Q1 2022 | $5,300,000 | +16.3% | 138,195 | -2.9% | 0.40% | +25.3% |
| Q4 2021 | $4,559,000 | -6.2% | 142,325 | -13.7% | 0.32% | -19.6% |
| Q3 2021 | $4,861,000 | -12.9% | 164,965 | +0.5% | 0.40% | -9.1% |
| Q2 2021 | $5,580,000 | +44.1% | 164,215 | +37.8% | 0.44% | +37.3% |
| Q1 2021 | $3,873,000 | -48.2% | 119,180 | -42.5% | 0.32% | -52.4% |
| Q4 2020 | $7,470,000 | -8.4% | 207,385 | -0.5% | 0.67% | -21.5% |
| Q3 2020 | $8,159,000 | -23.9% | 208,360 | -28.7% | 0.85% | -23.3% |
| Q2 2020 | $10,718,000 | – | 292,210 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |